The sequence of application of methotrexate and histone deacetylase inhibitors determines either a synergistic or an antagonistic response in childhood acute lymphoblastic leukemia cells

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2011-02, Vol.25 (2), p.359-361
Hauptverfasser:	Bastian, L, Einsiedel, H G, Henze, G, Seeger, K, Shalapour, S
Format:	Artikel
Sprache:	eng
Schlagworte:	631/92/436 692/699/67/1990/283/2125 692/700/1720 692/700/565/1436/1437 Acute lymphoblastic leukemia Acute lymphocytic leukemia Biological and medical sciences Cancer Research Cell Line, Tumor Child Children Critical Care Medicine Drug Antagonism Drug Synergism Drug therapy Health aspects Hematologic and hematopoietic diseases Hematology Histone deacetylase Histone Deacetylase Inhibitors - administration & dosage Humans Indexing in process Intensive Internal Medicine letter-to-the-editor Leukemia Leukemia in children Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphatic leukemia Lymphoblastic leukemia in children Lymphocytic leukemia in children Medical sciences Medicine Medicine & Public Health Methotrexate Methotrexate - administration & dosage Oncology Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Risk factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!